Tandem Diabetes Care Inc logo

TNDM - Tandem Diabetes Care Inc Share Price

$98.88 -0.0  -0.0%

Last Trade - 01/07/20

Sector
Healthcare
Size
Large Cap
Market Cap £4.77bn
Enterprise Value £4.64bn
Revenue £316.1m
Position in Universe 991st / 6345
Bullish
Bearish
Unlock TNDM Revenue
Momentum
Relative Strength (%)
1m +16.0%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -0.95%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
49.7 72.9 84.2 107.6 183.9 362.3 415.9 507.9 +48.8%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 31 March 2020, Tandem Diabetes Care Inc revenues increased 48% to $97.9M. Net loss decreased 35% to $14.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects FV Adjustments of Financial Investments decrease of 85% to $1.9M (expense), Interest and other expense decrease from $6K (expense) to $0K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

TNDM Revenue Unlock TNDM Revenue

Net Income

TNDM Net Income Unlock TNDM Revenue

Normalised EPS

TNDM Normalised EPS Unlock TNDM Revenue

PE Ratio Range

TNDM PE Ratio Range Unlock TNDM Revenue

Dividend Yield Range

TNDM Dividend Yield Range Unlock TNDM Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
TNDM EPS Forecasts Unlock TNDM Revenue
Profile Summary

Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim X2 Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump's cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.

Directors
Last Annual December 31st, 2019
Last Interim March 31st, 2020
Incorporated January 7, 2008
Public Since November 13, 2013
No. of Shareholders: 48
No. of Employees: 1,043
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite ,
Exchange NASDAQ Global Market
Shares in Issue 60,102,978
Free Float (0.0%)
Eligible for
ISAs
SIPPs
TNDM Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for TNDM
Upcoming Events for TNDM
Thursday 30th July, 2020 Estimate
Q2 2020 Tandem Diabetes Care Inc Earnings Release
Monday 2nd November, 2020 Estimate
Q3 2020 Tandem Diabetes Care Inc Earnings Release
Frequently Asked Questions for Tandem Diabetes Care Inc
What is the Tandem Diabetes Care Inc share price?

As of 01/07/20, shares in Tandem Diabetes Care Inc are trading at $98.88, giving the company a market capitalisation of £4.77bn. This share price information is delayed by 15 minutes.

How has the Tandem Diabetes Care Inc share price performed this year?

Shares in Tandem Diabetes Care Inc are currently trading at $98.88 and the price has moved by 55.74% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Tandem Diabetes Care Inc price has moved by 50.49% over the past year.

What are the analyst and broker recommendations for Tandem Diabetes Care Inc?

Of the analysts with advisory recommendations for Tandem Diabetes Care Inc, there are there are currently 1 "buy" , 6 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Tandem Diabetes Care Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Tandem Diabetes Care Inc next release its financial results?

Tandem Diabetes Care Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Tandem Diabetes Care Inc dividend yield?

Tandem Diabetes Care Inc does not currently pay a dividend.

Does Tandem Diabetes Care Inc pay a dividend?

Tandem Diabetes Care Inc does not currently pay a dividend.

When does Tandem Diabetes Care Inc next pay dividends?

Tandem Diabetes Care Inc does not currently pay a dividend.

How do I buy Tandem Diabetes Care Inc shares?

To buy shares in Tandem Diabetes Care Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Tandem Diabetes Care Inc?

Shares in Tandem Diabetes Care Inc are currently trading at $98.88, giving the company a market capitalisation of £4.77bn.

Where are Tandem Diabetes Care Inc shares listed? Where are Tandem Diabetes Care Inc shares listed?

Here are the trading details for Tandem Diabetes Care Inc:

Country of listing: United States
Exchange: NMQ
Ticker Symbol: TNDM
What kind of share is Tandem Diabetes Care Inc?

Based on an overall assessment of its quality, value and momentum, Tandem Diabetes Care Inc is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Tandem Diabetes Care Inc share price forecast 2020?

Shares in Tandem Diabetes Care Inc are currently priced at $98.88. At that level they are trading at 2.45% premium to the analyst consensus target price of 0.00.

Analysts covering Tandem Diabetes Care Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.489 for the next financial year.

How can I tell whether the Tandem Diabetes Care Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Tandem Diabetes Care Inc. Over the past six months, the relative strength of its shares against the market has been 74.45%. At the current price of $98.88, shares in Tandem Diabetes Care Inc are trading at 40.89% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Tandem Diabetes Care Inc PE Ratio?

We were not able to find PE ratio data for Tandem Diabetes Care Inc.

Who are the key directors of Tandem Diabetes Care Inc?

Tandem Diabetes Care Inc's management team is headed by:

Dick Allen - LED
Kim Blickenstaff - CHM
Edward Cahill - IND
Douglas Roeder - IND
David Berger - EVP
Susan Morrison - EVP
John Sheridan - PRE
Brian Hansen - EVP
Leigh Vosseller - CFO
Rebecca Robertson - IND
Elizabeth Gasser - EVP
Kathleen McGroddy-Goetz - IND
Who are the major shareholders of Tandem Diabetes Care Inc?

Here are the top five shareholders of Tandem Diabetes Care Inc based on the size of their shareholding:

Wellington Management Company, LLP Investment Advisor/Hedge Fund
Percentage owned: 11.29% (6.79m shares)
Fidelity Management & Research Company Investment Advisor
Percentage owned: 8.83% (5.31m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 8.81% (5.29m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 6.25% (3.76m shares)
Hartford MidCap Fund Mutual Fund
Percentage owned: 2.93% (1.76m shares)
Similar to TNDM
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.